Toll Free: 1-888-928-9744

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Trachoma, Buruli Ulcer, Yaws, Chagas Disease, Leishmaniases), By Product Type And Segment Forecasts, 2019 - 2026

Published: Oct, 2019 | Pages: 90 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global neglected tropical disease (NTD) treatment market size is expected to reach USD 1.9 billion by 2026, expanding at a CAGR of 5.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing prevalence of neglected tropical diseases is considered to be the vital impact rendering driver.

According to the data published in the WHO in 2018, T.B. Gambiense is endemic in 24 countries of Central and West Africa. This caused around 98% of reported cases of sleeping sickness. Furthermore, according to the CDC, around 400 people are infected annually by dengue.

Moreover, according to the statistics published in the WHO in 2019, more than 1.5 billion or 24% of the world's population are infected with soil-transmitted helminthiases. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China.

Presence of pipeline vaccines and drugs is also considered to be one of the major factors driving the market growth over the forecast period. For instance, Bayer AG is developing Nifurtimox (BAYA2502), currently under phase III clinical trials for the treatment of Chagas disease. Furthermore, Johnson & Johnson Services Inc. is developing Bedaquiline 200mg monotherapy regimen which is under phase II clinical trials for the treatment of leprosy and the study is estimated to be completed in 2021.

In addition, Instituto Butantan and Merck & Co., Inc. collaborated to develop vaccines against dengue in 2018. The Instituto Butantan is developing a dengue vaccine candidate in Brazil, TV003, which is in an ongoing Phase III clinical trial. Merck & Co., Inc. will provide funds to Instituto Butantan for its development.

Presence of key players such as F. Hoffmann-La Roche Ltd, Bayer AG, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Eisai Co. Ltd., Sanofi, Astellas Pharma, Takeda Pharmaceutical Company Limited, and Gilead Sciences is expected to fuel to the overall market growth. Involvement of these players in new product development is considered to be the contributing factor for the NTD treatment market.

Further key findings from the report suggest:

• Dengue held the largest segment share in 2018 owing to its increasing prevalence rate

• Buruli ulcer is estimated to be the fastest growing segment over the forecast period owing to rising awareness about the disease

• In 2018, drugs were anticipated to be the largest product type segment

• Vaccines are estimated to be the fastest growing segment over the forecast period due to strong presence of pipeline products

• Asia Pacific dominated the neglected tropical disease treatment market in 2018

• Latin America is estimated to witness the fastest growth over the forecast period

• MEA held the second largest regional share in 2018 due to increasing burden of neglected tropical diseases in this region
 Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Market segmentation & scope
                  1.2. Information procurement
                      1.2.1. Purchased database
                      1.2.2. GVR's internal database
                      1.2.3. Secondary sources & third party perspectives
                      1.2.4. Primary research
                  1.3. Information analysis
                      1.3.1. Data analysis models
                  1.4. Market formulation & data visualization
                  1.5. Data validation & publishing
Chapter 2. Executive Summary
                  2.1. Market Outlook
                  2.2. Segment Outlook
                  2.3. Competitive Insights
Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends & Scope
                  3.1. Market Lineage outlook
                      3.1.1. Parent market outlook
                      3.1.2. Related/ancillary market outlook
                  3.2. Penetration & Growth Prospect Mapping
                  3.3. Reimbursement Framework
                  3.4. Market Dynamics
                      3.4.1. Market Driver Analysis
                          3.4.1.1. Favorable government initiative
                          3.4.1.2. Rising awareness of NTDs
                          3.4.1.3. Increasing burden of NTDs in tropical & subtropical countries
                      3.4.2. Market Restraint Analysis
                  3.5. Neglected tropical disease: Market Analysis Tools
                      3.5.1. Industry Analysis - Porter's
                          3.5.1.1. Supplier Power
                          3.5.1.2. Buyer Power
                          3.5.1.3. Substitution Threat
                          3.5.1.4. Threat from new entrant
                          3.5.1.5. Competitive rivalry
                      3.5.2. PESTEL Analysis
                          3.5.2.1. Political Landscape
                          3.5.2.2. Environmental Landscape
                          3.5.2.3. Social Landscape
                          3.5.2.4. Technology Landscape
                          3.5.2.5. Legal Landscape
                      3.5.3. Major Deals & Strategic Alliances Analysis
                          3.5.3.1. Joint Ventures
                          3.5.3.2. Mergers & Acquisitions
                          3.5.3.3. Licensing & Partnership
                          3.5.3.4. Technology Collaborations
                          3.5.3.5. Strategic Divestments
Chapter 4. Neglected Tropical Disease Treatment Market: Segment Analysis, By Disease, 2015 - 2026 (USD Million)
                  4.1. Definitions & Scope
                  4.2. Disease Market Share Analysis, 2018 & 2026
                  4.3. Segment Dashboard
                  4.4. Global Neglected Tropical Disease Treatment Market, By Disease, 2015 to 2026
                  4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
                      4.5.1. Dengue
                      4.5.2. Rabies
                      4.5.3. Trachoma
                      4.5.4. Buruli ulcer
                      4.5.5. Yaws
                      4.5.6. Leprosy
                      4.5.7. Chagas disease
                      4.5.8. Human African trypanosomiasis (sleeping sickness)
                      4.5.9. Leishmaniases
                      4.5.10. Soil-transmitted helminthiases
                      4.5.11. Others
Chapter 5. Neglected Tropical Disease Treatment market: Segment Analysis, By Product Type, 2015 - 2026 (USD Million)
                  5.1. Definitions & Scope
                  5.2. Product Type Market Share Analysis, 2018 & 2026
                  5.3. Segment Dashboard
                  5.4. Global Neglected Tropical Disease Treatment Market, By Product Type, 2015 to 2026
                  5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
                      5.5.1. Drugs
                      5.5.2. Vaccines
Chapter 6. Neglected Tropical Disease Treatment Market: Regional Market Analysis, By Region, 2015 - 2026 (USD Million)
                  6.1. Definitions & Scope
                  6.2. Regional Market Share Analysis, 2018 & 2026
                  6.3. Regional Market Dashboard
                  6.4. Regional Market Share and Leading Players, 2018
                  6.5. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
                      6.5.1. North America
                      6.5.2. Europe
                      6.5.3. Asia Pacific
                      6.5.4. Latin America
                      6.5.5. Middle East & Africa
                  6.6. Market Size, & Forecasts and Trend Analysis, 2019 to 2026:
                  6.7. North America
                      6.7.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                      6.7.2. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                      6.7.3. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.7.4. U.S.
                          6.7.4.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.7.4.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.7.5. Canada
                          6.7.5.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.7.5.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                  6.8. Europe
                      6.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                      6.8.2. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                      6.8.3. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.8.4. Germany
                          6.8.4.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.8.4.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.8.5. U.K.
                          6.8.5.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.8.5.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                  6.9. Asia Pacific
                      6.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                      6.9.2. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                      6.9.3. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.9.4. China
                          6.9.4.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.9.4.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.9.5. Japan
                          6.9.5.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.9.5.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.9.6. India
                          6.9.6.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.9.6.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.9.7. Indonesia
                          6.9.7.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.9.7.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.9.8. Singapore
                          6.9.8.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.9.8.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.9.9. Philippines
                          6.9.9.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.9.9.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                  6.10. Latin America
                      6.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                      6.10.2. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                      6.10.3. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.10.4. Brazil
                          6.10.4.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.10.4.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.10.5. Mexico
                          6.10.5.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.10.5.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.10.6. Argentina
                          6.10.6.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.10.6.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.10.7. Colombia
                          6.10.7.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.10.7.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.10.8. Bolivia
                          6.10.8.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.10.8.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                  6.11. Middle East and Africa
                      6.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
                      6.11.2. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                      6.11.3. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.11.4. South Africa
                          6.11.4.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.11.4.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.11.5. Saudi Arabia
                          6.11.5.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.11.5.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.11.6. UAE
                          6.11.6.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.11.6.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.11.7. Nigeria
                          6.11.7.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.11.7.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.11.8. Ghana
                          6.11.8.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.11.8.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
                      6.11.9. Zimbabwe
                          6.11.9.1. Market estimates and forecast, by disease, 2015 - 2026 (USD Million)
                          6.11.9.2. Market estimates and forecast, by product type, 2015 - 2026 (USD Million)
Chapter 7. Neglected Tropical Disease Treatment market - Competitive Analysis
                  7.1. Recent developments & impact analysis, by key market participants
                  7.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                  7.3. Public Companies
                      7.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                      7.3.2. Company Market Share/Ranking, by region
                      7.3.3. Competitive Dashboard Analysis
                  7.4. Private Companies
                      7.4.1. List of key emerging companies /technology disruptors/innovators
                      7.4.2. Regional network map
                      7.4.3. Company market position analysis
                  7.5. Key companies profiled
                      7.5.1. F. Hoffmann-La Roche Ltd
                          7.5.1.1. Company Overview
                          7.5.1.2. Financial Performance
                          7.5.1.3. Product Benchmarking
                          7.5.1.4. Strategic Initiatives
                      7.5.2. Bayer AG
                          7.5.2.1. Company Overview
                          7.5.2.2. Financial Performance
                          7.5.2.3. Product Benchmarking
                          7.5.2.4. Strategic Initiatives
                      7.5.3. GlaxoSmithKline plc
                          7.5.3.1. Company Overview
                          7.5.3.2. Financial Performance
                          7.5.3.3. Product Benchmarking
                          7.5.3.4. Strategic Initiatives
                      7.5.4. Novartis AG
                          7.5.4.1. Company Overview
                          7.5.4.2. Financial Performance
                          7.5.4.3. Product Benchmarking
                          7.5.4.4. Strategic Initiatives
                      7.5.5. Pfizer, Inc.
                          7.5.5.1. Company Overview
                          7.5.5.2. Financial Performance
                          7.5.5.3. Product Benchmarking
                          7.5.5.4. Strategic Initiatives
                      7.5.6. Eisai Co., Ltd.
                          7.5.6.1. Company Overview
                          7.5.6.2. Financial Performance
                          7.5.6.3. Product Benchmarking
                          7.5.6.4. Strategic Initiatives
                      7.5.7. Sanofi
                          7.5.7.1. Company Overview
                          7.5.7.2. Financial Performance
                          7.5.7.3. Product Benchmarking
                          7.5.7.4. Strategic Initiatives
                      7.5.8. Astellas Pharma
                          7.5.8.1. Company Overview
                          7.5.8.2. Financial Performance
                          7.5.8.3. Product Benchmarking
                          7.5.8.4. Strategic Initiatives
                      7.5.9. Gilead Sciences
                          7.5.9.1. Company Overview
                          7.5.9.2. Financial Performance
                          7.5.9.3. Product Benchmarking
                          7.5.9.4. Strategic Initiatives
                      7.5.10. Takeda Pharmaceutical Company Limited
                          7.5.10.1. Company Overview
                          7.5.10.2. Financial Performance
                          7.5.10.3. Product Benchmarking
                          7.5.10.4. Strategic Initiatives
List of Tables

TABLE 1 List of Abbreviation
TABLE 2 North America Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 3 North America Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 4 U.S. Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 5 U.S. Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 6 Canada Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 7 Canada Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 8 Europe Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 9 Europe Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 10 U.K. Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 11 U.K. Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 12 Germany Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 13 Germany Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 14 Asia Pacific Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 15 Asia Pacific Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 16 Japan Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 17 Japan Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 18 China Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 19 China Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 20 India Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 21 India Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 22 Indonesia Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 23 Indonesia Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 24 Singapore Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 25 Singapore Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 26 Philippines Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 27 Philippines Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 28 Latin America Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 29 Latin America Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 30 Mexico Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 31 Mexico Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 32 Brazil Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 33 Brazil Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 34 Argentina Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 35 Argentina Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 36 Colombia Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 37 Colombia Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 38 Bolivia Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 39 Bolivia Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 40 MEA Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 41 MEA Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 42 South Africa Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 43 South Africa Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 44 Saudi Arabia Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 45 Saudi Arabia Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 46 UAE Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 47 UAE Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 48 Nigeria Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 49 Nigeria Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 50 Ghana Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 51 Ghana Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million)
TABLE 52 Zimbabwe Neglected Tropical Disease Treatment Market, By Disease, 2015 - 2026 (USD Million)
TABLE 53 Zimbabwe Neglected Tropical Disease Treatment Market, By Product Type, 2015 - 2026 (USD Million) 


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global Neglected Tropical Disease Treatment market- Key market driver analysis
FIG. 7 Global Neglected Tropical Disease Treatment market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Global Neglected Tropical Disease Treatment market - Porter's analysis
FIG. 10 Global Neglected Tropical Disease Treatment market - PESTEL analysis
FIG. 11 Global Neglected Tropical Disease Treatment market disease outlook key takeaways
FIG. 12 Global Neglected Tropical Disease Treatment market: Disease movement analysis
FIG. 13 Dengue market estimates, 2015 - 2026 (USD Million)
FIG. 14 Rabies market estimates, 2015 - 2026 (USD Million)
FIG. 15 Trachoma market estimates, 2015 - 2026 (USD Million)
FIG. 16 Buruli ulcer market estimates, 2015 - 2026 (USD Million)
FIG. 17 Yaws market estimates, 2015 - 2026 (USD Million)
FIG. 18 Leprosy market estimates, 2015 - 2026 (USD Million)
FIG. 19 Chagas disease market estimates, 2015 - 2026 (USD Million)
FIG. 20 Human African trypanosomiasis (sleeping sickness) market estimates, 2015 - 2026 (USD Million)
FIG. 21 Leishmaniases market estimates, 2015 - 2026 (USD Million)
FIG. 22 Soil-transmitted helminthiases market estimates, 2015 - 2026 (USD Million)
FIG. 23 Others market estimates, 2015 - 2026 (USD Million)
FIG. 24 Global Neglected Tropical Disease Treatment market Product type outlook key takeaways
FIG. 25 Global Neglected Tropical Disease Treatment market: Product type movement analysis
FIG. 26 Drugs market estimates, 2015 - 2026 (USD Million)
FIG. 27 Vaccines market estimates, 2015 - 2026 (USD Million)
FIG. 28 Regional marketplace: Key takeaways
FIG. 29 Global Neglected Tropical Disease Treatment market: Regional movement analysis
FIG. 30 North America Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 31 U.S. Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 32 Canada Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 33 Europe Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 34 U.K. Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 35 Germany Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 36 Asia Pacific Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 37 Japan Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 38 China Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 39 India Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 40 Indonesia Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 41 Singapore Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 42 Philippines Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 43 Latin America Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG 44 Brazil Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 45 Mexico Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 46 Argentina Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 47 Colombia Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 48 Bolivia Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million
FIG. 49 MEA Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 50 South Africa Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 51 Saudi Arabia Neglected Tropical Disease Treatment market, 2015 - 2026 (USD Million)
FIG. 52 UAE market, 2015 - 2026 (USD Million)
FIG. 53 Nigeria market, 2015 - 2026 (USD Million)
FIG. 54 Ghana market, 2015 - 2026 (USD Million)
FIG. 55 Zimbabwe market, 2015 - 2026 (USD Million)
FIG. 56 Strategy framework

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $5950
Multi User - US $6950
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify